| Hidalgo I, Gonzalez S. New epigenetic pathway for stemness maintenance mediated by the histone methyltransferase Ezh1. Cell Cycle (2013) 12:383-4 |
| Hidalgo I, Herrera-Merchan A, Ligos JM, Carramolino L, Nuñez J, Martinez F, Dominguez O, Torres M, Gonzalez S. Ezh1 Is Required for Hematopoietic Stem Cell Maintenance and Prevents Senescence-like Cell Cycle Arrest. Cell Stem Cell (2012) 11:649-62 |
| Herrera-Merchan A, Arranz L, Ligos JM, de Molina A, Dominguez O, Gonzalez S. Ectopic expression of the histone methyltransferase Ezh2 in haematopoietic stem cells causes myeloproliferative disease. Nat Commun (2012) 3:623 |
| Arranz L, Herrera-Merchan A, Ligos JM, de Molina A, Dominguez O, Gonzalez S. Bmi1 is critical to prevent Ikaros-mediated lymphoid priming in hematopoietic stem cells. Cell Cycle (2012) 11:65-78 |
| Arranz L, Herrera-Merchan A, Gonzalez S. Therapeutic Polycomb targeting in human cancer. Recent Pat Reg Med (2012) 2:22-29 |
| Mittelbrunn M, Gutiérrez-Vázquez C, Villarroya-Beltri C, González S, Sánchez-Cabo F, González MÁ, Bernad A, Sánchez-Madrid F. Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat Commun (2011) 2:282 |
| Herrera-Merchan A, Cerrato C, Luengo G, Dominguez O, Piris MA, Serrano M, Gonzalez S. miR-33-mediated downregulation of p53 controls hematopoietic stem cell self-renewal. Cell Cycle (2010) 9:3277-85 |
| Daroca PM, Herrera-Merchan A, Gonzalez S. Insights into stem cell aging,. Nat Rev Cardiol (cnic Edition) (2010) 7:11-15 |
| de Yebenes VG, Belver L, Pisano DG, Gonzalez S, Villasante A, Croce C, He L, Ramiro AR. miR-181b negatively regulates activation-induced cytidine deaminase in B cells. J Exp Med (2008) 205:2199-206 |
| Benetti R, Gonzalo S, Jaco I, Muñoz P, Gonzalez S, Schoeftner S, Murchison E, Andl T, Chen T, Klatt P, Li E, Serrano M, Millar S, Hannon G, Blasco MA. A mammalian microRNA cluster controls DNA methylation and telomere recombination via Rbl2-dependent regulation of DNA methyltransferases. Nat Struct Mol Biol (2008) 15:998 |
Susana Gonzalez obtained her degree in Chemistry and Molecular Biology at the Universidad Autónoma de Madrid in 1994. Susana devoted her thesis work to the study of the molecular mechanisms of influenza virus under the supervision of Dr. Juan Ortin at the Centro Nacional de Biotecnología in Madrid. She received her PhD from the Universidad Autónoma de Madrid.
In 2000, Susana was awarded a postdoctoral fellowship from the Human Frontier Science Program (HFSP) to work in New York with Carlos Cordon-Cardo at the Memorial Sloan-Kettering Cancer Center and Carol Prives at Columbia University. Her work in this period focused on different tumor suppression responses. She subsequently moved to Manuel Serrano’s laboratory at the Spanish National Cancer Research Center (Centro Nacional de Investigaciones Oncológicas, in Madrid), where her work helped identify the mechanisms governing the expression of the INK4/ARF locus and the mechanisms through which miRNAs induce heterochromatinization to silence gene promoters. In 2006 Susana was granted an HFSP Career Development Award. She joined the CNIC in 2007.